Skip to content
+1 (949) 670-0403
Tisgenx
Tisgenx
Home
About Us
Technology
Products
Invengenx® – Cardiothoracic
Vascugenx™ – Vascular
Urogenx™ – Urology
Surgenx™ – General Surgery
Distributor
Resources
Events
News
Publications
Training
Contact Us
News
Correction to: Hemostatic efcacy of a fowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial
Posted on
September 15, 2023
September 20, 2023
by